Literature DB >> 14678786

Altered proteasome function and subunit composition in aged muscle.

Aimee D Husom1, Elizabeth A Peters, Erin A Kolling, Nicole A Fugere, LaDora V Thompson, Deborah A Ferrington.   

Abstract

Myofibrillar protein degradation is mediated through the ubiquitin-proteasome pathway. To investigate if altered proteasome activity plays a role in age-related muscle atrophy, we examined muscle size and proteasome function in young and aged F344BN rats. Significant age-related muscle atrophy was confirmed by the 38% decrease in cross-sectional area of type 1 fibers in soleus muscle. Determination of proteasome function showed hydrolysis of fluorogenic peptides was equivalent between ages. However, when accounting for the 3-fold increase in content of the 20S catalytic core in aged muscle, the lower specific activity suggests a functional loss in individual proteins with aging. Comparing the composition of the catalytic beta-subunits showed an age-related 4-fold increase in the cytokine-inducible subunits, LMP2 and LMP7. Additionally, the content of the activating complexes, PA28 and PA700, relative to the 20S proteasome was reduced 50%. These results suggest significant alterations in the intrinsic activity, the percentage of immunoproteasome, and the regulation of the 20S proteasome by PA28 and PA700 in aged muscle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678786     DOI: 10.1016/j.abb.2003.10.010

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  68 in total

1.  Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress.

Authors:  Andrew M Pickering; Robert A Linder; Hongqiao Zhang; Henry J Forman; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

Review 2.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

3.  Immunoproteasome deficiency alters retinal proteasome's response to stress.

Authors:  Stacy A Hussong; Rebecca J Kapphahn; Stacia L Phillips; Marcela Maldonado; Deborah A Ferrington
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

Review 4.  Degradation of damaged proteins: the main function of the 20S proteasome.

Authors:  Andrew M Pickering; Kelvin J A Davies
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

6.  Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.

Authors:  Pietro Fratta; W King Engel; Janis McFerrin; Kelvin J A Davies; Sharon W Lin; Valerie Askanas
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina.

Authors:  Rebecca J Kapphahn; Erin J Bigelow; Deborah A Ferrington
Journal:  Exp Eye Res       Date:  2007-01-25       Impact factor: 3.467

8.  Immunoproteasome in animal models of Duchenne muscular dystrophy.

Authors:  Chiao-Nan Joyce Chen; Ted G Graber; Wendy M Bratten; Deborah A Ferrington; LaDora V Thompson
Journal:  J Muscle Res Cell Motil       Date:  2014-06-17       Impact factor: 2.698

9.  A Sensitive High-Throughput Screening Method for Identifying Small Molecule Stimulators of the Core Particle of the Proteasome.

Authors:  Rachel A Coleman; Darci J Trader
Journal:  Curr Protoc Chem Biol       Date:  2018-10-04

10.  Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome.

Authors:  Zhaoqing Yang; Dmitry Gagarin; Georges St Laurent; Neil Hammell; Ian Toma; Chien-An Hu; Ayaka Iwasa; Timothy A McCaffrey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-05-14       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.